Cancerrisiko ved topikale immunmodulatorer

Mette Deleuran, Claus Zachariae, Kristian Thestrup-Pedersen

2 Citationer (Scopus)

Abstract

This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.

Bidragets oversatte titelTopical immune modulation and risk of cancer
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind171
Udgave nummer35
Sider (fra-til)2468-71
Antal sider4
ISSN0041-5782
StatusUdgivet - 24 aug. 2009

Emneord

  • Administration, Topical
  • Adult
  • Child
  • Dermatitis, Atopic
  • Humans
  • Immunosuppressive Agents
  • Lymphoma
  • Risk Factors
  • Skin Neoplasms
  • Tacrolimus

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cancerrisiko ved topikale immunmodulatorer'. Sammen danner de et unikt fingeraftryk.

Citationsformater